{"id":"https://openalex.org/W2901487294","doi":"https://doi.org/10.1128/aac.01715-18","title":"APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental Coccidioides immitis Pneumonia","display_name":"APX001 and Other Gwt1 Inhibitor Prodrugs Are Effective in Experimental Coccidioides immitis Pneumonia","alternate_titles":[],"publication_year":2018,"publication_date":"2018-11-15","ids":{"openalex":"https://openalex.org/W2901487294","doi":"https://doi.org/10.1128/aac.01715-18","mag":"2901487294","pmid":"https://pubmed.ncbi.nlm.nih.gov/30455238","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6355600"},"language":"en","primary_location":{"id":"doi:10.1128/aac.01715-18","doi":"https://doi.org/10.1128/aac.01715-18","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.01715-18","pdf_url":"https://aac.asm.org/content/aac/63/2/e01715-18.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2901487294"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://aac.asm.org/content/aac/63/2/e01715-18.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035373924","display_name":"Suganya Viriyakosol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099595","display_name":"VA San Diego Healthcare System","ror":"https://ror.org/00znqwq11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210099595","https://openalex.org/I4210138663"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suganya Viriyakosol","raw_affiliation_strings":["VA Healthcare, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VA Healthcare, San Diego, California, USA","institution_ids":["https://openalex.org/I4210099595"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068879729","display_name":"Mili Kapoor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mili Kapoor","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010157805","display_name":"Sharon Okamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800935791","display_name":"UC San Diego Health System","ror":"https://ror.org/01kbfgm16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2800935791","https://openalex.org/I36258959"]},{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sharon Okamoto","raw_affiliation_strings":["Division of Infectious Diseases, Department of Medicine, UC San Diego School of Medicine, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine, UC San Diego School of Medicine, San Diego, California, USA","institution_ids":["https://openalex.org/I2800935791","https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074529368","display_name":"Jonathan A. Covel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Covel","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087949227","display_name":"Quinlyn A. Soltow","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Quinlyn A. Soltow","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027409273","display_name":"Michael Trzoss","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Trzoss","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086601088","display_name":"Karen Joy Shaw","orcid":"https://orcid.org/0000-0003-3060-1328","observed_orcids":["https://orcid.org/0000-0003-3060-1328"]},"institutions":[{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Karen Joy Shaw","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052552759","display_name":"Joshua Fierer","orcid":"https://orcid.org/0000-0002-9230-5279","observed_orcids":["https://orcid.org/0000-0002-9230-5279"]},"institutions":[{"id":"https://openalex.org/I4210099595","display_name":"VA San Diego Healthcare System","ror":"https://ror.org/00znqwq11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210099595","https://openalex.org/I4210138663"]},{"id":"https://openalex.org/I4210108517","display_name":"Amplyx Pharmaceuticals (United States)","ror":"https://ror.org/02jfsdq79","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108517"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Joshua Fierer","raw_affiliation_strings":["Amplyx Pharmaceuticals, San Diego, California, USA","VA Healthcare, San Diego, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amplyx Pharmaceuticals, San Diego, California, USA","institution_ids":["https://openalex.org/I4210108517"]},{"raw_affiliation_string":"VA Healthcare, San Diego, California, USA","institution_ids":["https://openalex.org/I4210099595"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5052552759","https://openalex.org/A5086601088"],"corresponding_institution_ids":["https://openalex.org/I4210099595","https://openalex.org/I4210108517"],"apc_list":null,"apc_paid":null,"fwci":5.3883,"has_fulltext":true,"cited_by_count":63,"citation_normalized_percentile":{"value":0.96635428,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"63","issue":"2","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.20649999380111694,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12369","display_name":"Pneumocystis jirovecii pneumonia detection and treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/coccidioides-immitis","display_name":"Coccidioides immitis","score":0.8389999866485596},{"id":"https://openalex.org/keywords/coccidioidomycosis","display_name":"coccidioidomycosis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.7360000014305115},{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.8529999852180481},{"id":"https://openalex.org/keywords/mycelial-growth-inhibition","display_name":"mycelial growth inhibition","score":0.8190000057220459},{"id":"https://openalex.org/keywords/oral-antifungal-therapy","display_name":"oral antifungal therapy","score":0.8220000267028809},{"id":"https://openalex.org/keywords/1-aminobenzotriazole","display_name":"1-aminobenzotriazole","score":0.8799999952316284},{"id":"https://openalex.org/keywords/fluconazole","display_name":"fluconazole","score":0.7369999885559082},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.3240000009536743},{"id":"https://openalex.org/keywords/disseminated-infection","display_name":"disseminated infection","score":0.4169999957084656}],"concepts":[{"id":"https://openalex.org/C2778439347","wikidata":"https://www.wikidata.org/wiki/Q5139154","display_name":"Coccidioides immitis","level":2,"score":0.9610975384712219},{"id":"https://openalex.org/C2781030883","wikidata":"https://www.wikidata.org/wiki/Q142764","display_name":"Coccidioides","level":2,"score":0.7221754789352417},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.5977441072463989},{"id":"https://openalex.org/C21717790","wikidata":"https://www.wikidata.org/wiki/Q3291858","display_name":"Dimorphic fungus","level":3,"score":0.589046835899353},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.5654878616333008},{"id":"https://openalex.org/C2780315139","wikidata":"https://www.wikidata.org/wiki/Q419639","display_name":"Azole","level":3,"score":0.5488702058792114},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47915953397750854},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.312982439994812},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.2390480935573578},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10661795735359192},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2779222958","wikidata":"https://www.wikidata.org/wiki/Q45422","display_name":"Yeast","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000631","descriptor_name":"Aminopyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000666","descriptor_name":"Amphotericin B","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003045","descriptor_name":"Coccidioides","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003045","descriptor_name":"Coccidioides","qualifier_ui":"Q000472","qualifier_name":"pathogenicity","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011014","descriptor_name":"Pneumonia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011355","descriptor_name":"Prodrugs","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015725","descriptor_name":"Fluconazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.01715-18","doi":"https://doi.org/10.1128/aac.01715-18","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.01715-18","pdf_url":"https://aac.asm.org/content/aac/63/2/e01715-18.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6355600","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6355600/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6355600/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmh:oai:europepmc.org:5341208","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6355600","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:30455238","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30455238","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1128/aac.01715-18","doi":"https://doi.org/10.1128/aac.01715-18","is_oa":true,"landing_page_url":"https://doi.org/10.1128/aac.01715-18","pdf_url":"https://aac.asm.org/content/aac/63/2/e01715-18.full.pdf","source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3932920183","display_name":null,"funder_award_id":"R44 AI125017","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G5397867391","display_name":"Developing a Novel, Fungicidal Therapeutic to Treat Coccidioidomycosis","funder_award_id":"R44AI125017","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G567790313","display_name":null,"funder_award_id":"1R44AI125017-01","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G672393687","display_name":"Development of a new class of antifungals effective against Cryptococcus","funder_award_id":"R01AI144091","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320306127","display_name":"U.S. Department of Veterans Affairs","ror":"https://ror.org/05rsv9s98"},{"id":"https://openalex.org/F4320317395","display_name":"Amplyx","ror":"https://ror.org/02jfsdq79"},{"id":"https://openalex.org/F4320321837","display_name":"Ministerio de Econom\u00eda y Competitividad","ror":"https://ror.org/034900433"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2901487294.pdf","grobid_xml":"https://content.openalex.org/works/W2901487294.grobid-xml"},"referenced_works_count":46,"referenced_works":["https://openalex.org/W391620583","https://openalex.org/W615254675","https://openalex.org/W1529712545","https://openalex.org/W1902677919","https://openalex.org/W1979721512","https://openalex.org/W1984227450","https://openalex.org/W2014616328","https://openalex.org/W2020769754","https://openalex.org/W2071969409","https://openalex.org/W2077223232","https://openalex.org/W2080906371","https://openalex.org/W2086040972","https://openalex.org/W2088337769","https://openalex.org/W2102705829","https://openalex.org/W2110436000","https://openalex.org/W2117048934","https://openalex.org/W2125226560","https://openalex.org/W2135066925","https://openalex.org/W2144566911","https://openalex.org/W2151215691","https://openalex.org/W2157068508","https://openalex.org/W2160628792","https://openalex.org/W2184546388","https://openalex.org/W2195029035","https://openalex.org/W2322316755","https://openalex.org/W2468928916","https://openalex.org/W2479157738","https://openalex.org/W2560462942","https://openalex.org/W2575268702","https://openalex.org/W2594895580","https://openalex.org/W2746687770","https://openalex.org/W2748363377","https://openalex.org/W2754274550","https://openalex.org/W2783397783","https://openalex.org/W2792314560","https://openalex.org/W2805470919","https://openalex.org/W2884671633","https://openalex.org/W2904985710","https://openalex.org/W2913512850","https://openalex.org/W2983290671","https://openalex.org/W2990471894","https://openalex.org/W2999574124","https://openalex.org/W3006793634","https://openalex.org/W3011124650","https://openalex.org/W4242945259","https://openalex.org/W7132385118"],"related_works":["https://openalex.org/W3184138977","https://openalex.org/W2884671633","https://openalex.org/W2783397783","https://openalex.org/W2754448271","https://openalex.org/W3119728070","https://openalex.org/W2792314560","https://openalex.org/W2752605326","https://openalex.org/W2981971993","https://openalex.org/W2805470919","https://openalex.org/W2900712152"],"abstract_inverted_index":{",":[0],"inhibiting":[1],"hyphal":[2],"growth":[3],"at":[4,92],"low":[5],"nanogram/ml":[6],"concentrations.":[7],"APX001":[8,36,114],"is":[9],"the":[10,20,38,47,86],"N-phosphonooxymethyl":[11],"prodrug":[12,39],"of":[13,22,35,46,67,71,88,118,122],"APX001A,":[14],"currently":[15],"in":[16],"clinical":[17],"trials":[18],"for":[19,132],"treatment":[21,72],"invasive":[23],"fungal":[24],"infections.":[25],"Mice":[26],"were":[27],"treated":[28],"orally":[29,91],"once":[30],"daily":[31],"with":[32],"26":[33],"mg/kg/day":[34],"and":[37,59,81,103,111,115],"analog":[40],"APX2097,":[41],"2":[42],"h":[43],"after":[44],"administration":[45],"pan-cytochrome":[48],"P450":[49],"inhibitor":[50],"1-aminobenzotriazole,":[51],"which":[52],"was":[53],"used":[54],"to":[55,61,85],"enhance":[56],"drug":[57],"half-life":[58],"exposures":[60],"more":[62],"closely":[63],"mimic":[64],"human":[65],"pharmacokinetics":[66],"APX001A.":[68],"Five":[69],"days":[70],"reduced":[73],"lung":[74],"colony":[75],"counts":[76],"by":[77],"nearly":[78],"3":[79],"logs":[80],"prevented":[82],"dissemination,":[83],"similar":[84],"efficacy":[87],"fluconazole":[89],"dosed":[90],"25":[93],"mg/kg":[94],"twice":[95],"daily.":[96],"In":[97],"a":[98],"survival":[99],"experiment,":[100],"both":[101],"APX001-":[102],"APX2097-treated":[104],"mice":[105],"survived":[106],"significantly":[107],"longer":[108],"than":[109],"control":[110],"fluconazole-treated":[112],"mice.":[113],"other":[116],"members":[117],"this":[119],"new":[120],"class":[121],"antifungal":[123],"agents":[124],"may":[125],"offer":[126],"great":[127],"promise":[128],"as":[129],"effective":[130],"therapies":[131],"coccidioidomycosis.":[133]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2901487294","counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":7}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2018-11-29T00:00:00"}
